Clinical Trials Browser

Glioblastoma, Recurrence

Nasopharyngeal Carcinoma

Lung Neoplasms

Carcinoma, Hepatocellular, Cholangiocarcinoma

Prostatic Neoplasms

Breast Neoplasms

Triple Negative Breast Neoplasms

Oropharyngeal Neoplasms, Tonsillar Neoplasms

Head and Neck Carcinoma

Fibrosis, Carcinoma, Hepatocellular, Cholangiocarcinoma

Mouth Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Mycosis Fungoides

Borderline Resectable Pancreatic Adenocarcinoma

Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified

Breast Neoplasms

Salivary Gland Neoplasms

Glioblastoma, Glioma, Neurofibromatosis 1

Carcinoma, Squamous Cell

Breast Neoplasms

Prostate Adenocarcinoma

Neoplasm Metastasis

Pancreatic Neoplasms

Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Carcinoma, Hepatocellular

Prostatic Neoplasms

Carcinoma, Oropharyngeal Neoplasms

Glioblastoma, Gliosarcoma

Prostatic Neoplasms

Oropharyngeal Neoplasms

Colorectal Neoplasms

Prostatic Neoplasms

Multiple Myeloma

Glioblastoma, Gliosarcoma

Clinical Trials

GBM AGILE

Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial

GAPP Induction and Concurrent Chemoradiotherapy for High-risk Locoregionally Advanced NPC.

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer

DIVINE

ART

High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer

Lombardi197

Bioelectrical Impedance Analysis in Estimating Body Composition in Patients With Stage I-IV Head and Neck Cancer Undergoing Radiation Therapy

Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function

Clinical and Molecular Features of Oral Premalignancy and Oral Cancer

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides

New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

DEBRA

Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas

NF118

The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer

Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial

LAP100

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Biomarker-Driven Radiation Therapy Dose Reduction After Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer

Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases

FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial

Hypofractionation (Radiation) Trial for Multiple Myeloma

Hyperpolarized Imaging in Diagnosing Participants With Glioma

Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma